A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yields
Y. Fujioka, S. Kashiwagi, A. Yoshida, A. O. Satoh, M. Fujioka, M. Amano, Y. Yamauchi, Y. Ohba
This paper describes an improved method to produce SARS-CoV and SARS-CoV-2 Spike protein pseudotyped VSV particles for coronavirus entry studies and antiviral development.
bioRxiv · Jul 30, 2021 · PreprintMicrobiology